Skip to main content

Israel continues to deny travel permits to Gaza cancer patients

Despite its acknowledged humanitarian responsibility toward the residents of Gaza, a ruling by the Israeli Supreme Court to allow five cancer-stricken relatives of Hamas members to travel for treatment is a notable exception to policy.
RTXZ3BT.jpg
Read in 

First, the good news: Israel’s Supreme Court ordered the government Aug. 26 to allow five critically ill Palestinian women from the Gaza Strip to leave immediately for life-saving treatment in an East Jerusalem hospital. Their only sin, according to the state’s affidavit, was being immediate relatives of a Hamas member. Originally, several human rights organizations (Gisha, Al-Mizan, Adalah and Physicians for Human Rights) petitioned the court on behalf of seven women banned from traveling for medical care in Israel. In the wake of the petition, the state admitted it had mistaken two of the plaintiffs for immediate relatives of Hamas members. The two plaintiffs were instructed to apply again for a permission to leave the Strip, but one was so drained that she gave up on re-starting the exhausting bureaucratic process of applying for permission to access critical medical care.

The head of the three-judge panel, Justice Uzi Vogelman, wrote of the decision to deny the women access to medical care in East Jerusalem, "It does not place appropriate weight on the value of human life nor on the absence of any involvement by said patient in illegal activities of any sort. Therefore, the decision does not fall within the bounds of reasonableness." His colleague Justice Isaac Amit concurred. “The decision to cause the death of a woman, pure and simple, for the sins of her brother or husband, contradicts the basic Jewish principle that each man shall die for his own sins,” he wrote.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.